Successful improvement of frequency and symptoms of premature complexes after oral magnesium administration

Arquivos Brasileiros de Cardiologia

Volumn 98, Issue 6, 2012, Pages 480-487

  de Falco, Cristina Nádja Muniz Lima ^a,b   Grupi, Cesar ^a   Sosa, Eduardo ^a   Scanavacca, Maurício ^a   Hachul, Denise ^a   Lara, Sissy ^a   Sacilotto, Luciana ^a   Pisani, Cristiano F ^a   Ramires, José A F ^a   Darrieux, Francisco ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Clínica Médica Core Vita   (Brazil)

Author keywords

Arrhythmias; Cardiac; Ion channels; Magnesium; Ventricular premature complexes

Indexed keywords

MAGNESIUM ION; PLACEBO; PYROGLUTAMATE MAGNESIUM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART ARRHYTHMIA; HEART RHYTHM; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; SUPRAVENTRICULAR COMPLEX; SYMPTOM; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; ATRIAL PREMATURE COMPLEXES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBO EFFECT; PYRROLIDONECARBOXYLIC ACID; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR PREMATURE COMPLEXES; YOUNG ADULT;

EID: 84866124758     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2012005000043     Document Type: Article

References (28)

1. Barret PA, Peter CT, Swan HJ, Singh BN, Mandel WJ. The frequency and prognostic significance of electrocardiographic abnormalities in clinically normal individuals. Prog Cardiovasc Dis.1981;23(4):299-319.
2. DePaula RS, Antelmi I, Vincenzi MA, André CD, Artes R, Grupi CJ, et al. Cardiac arrhythmias and atrioventricular block in a cohort of asymptomatic individuals without heart disease. Cardiology. 2007;108(2):111-6.
3. Rasmussen V, Jensen G, Schnohr P, Hansen JF. Premature ventricular beats in healthy adult subjects 20 to 79 years of age. Eur Heart J. 1985;6(4):335-41.
4. Wajngarten M, Grupi C, Bellotti GM, Da Luz PL, Azul LG, Pileggi F. Frequency and significance of cardiac rhythm disturbances in healthy elderly individuals. J Electrocardiol. 1990;23(2):171-6.
5. Hiss RG, Averill KH, Lamb LE. Ellectrocardiographic findings in 67,375 asymptomatic subjects. III. Ventricular rhythms. Am J Cardiol.1960;6:96-107.
6. Darrieux FC, Scanavacca MI, Hachul DT, Melo SL, D ́Ávilla AB, Gruppi CJ, et al. Ablação com radiofreqüência de extra-sístoles da via de saída do ventrículo direito. Arq Bras Cardiol. 2007;88(3):265-72.
7. Huskisson E, Maggini S, Ruf M. The role of vitamins and minerals in energy metabolism and well-being. J Int Med Res. 2007;35(3):277-89.
8. Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev. 2003;24(2):47-66.
9. Wu J, Carter A. Magnesium: the forgotten electrolyte. Aust Prescr. 2007;30:102-5.
10. Ebel H, Gunther TJ. Magnesium metabolism: a review. Clin Chem Clin Biochem. 1980;18(5)257-70.
11. Elin RJ. Laboratory tests for the assessment of magnesium status in humans. Magnes Trace Elem. 1991-1992;10(2-4):172-81.
12. Arnaud MJ. Update on the assessment of magnesium status. Br J Nutr. 2008;99(Suppl.3):S24-36.
13. Marier JR. Magnesium content of the food supply in the modern-day world. Magnesium. 1986;5(1):1-8.
14. Gums JG. Magnesium in cardiovascular and other disorders. Am J Health Syst Pharm. 2004;61(15):1569-76.
15. nd ed. Massachusetts, USA: Wiley Blackwell; 2003.
16. Neter J, Kuntner MH, Nachtsheim CJ, Wasserman W. Applied linear statistical models. 4th ed. Illinois:McGraw Hill/Irwing;1996.
17. Zehender M, Meinertz T, Faber T, Caspary A, Jeron A, Bremm K, et al. Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. Magnesium in Cardiac Arrhythmias (MAGICA) Investigators. J Am Coll Cardiol. 1997;29(5):1028-34.
18. Silver BB. Development of cellular magnesium nano-analysis in treatment of clinical magnesium deficiency. J Am Coll Nutr. 2004;23(6):732S-7S.
19. 2+ in association with spontaneous rhythmic contraction in cultured cardiac myocytes. Chronobiol Int. 2008;25(6):868-81.
20. Chubanov V, Waldegger S, Mederos y Schnitzler M, Vitzthum H, Sassen MC, Seyberth HW, et al. Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes by hypomagnesemia with secondary hypocalcemia. Proc Natl Acad Sci U S A. 2004;101(9):2894-9.
21. 2+ absorption. J Biol Chem. 2004;279(1):19-25.
22. Belin RJ, He K. Magnesium physiology and pathogenic mechanisms that contribute to the development of the metabolic syndrome. Magnes Res. 2007;20(2):107-29.
23. He K, Liu K, Daviglus ML, Morris SJ, Loria CM, Van Horn L, et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation. 2006;113(13):1675-82.
24. Wirell MP, Wester PO, Stegmayr BG. Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: a double-blind, cross-over study. J Intern Med. 1994;236(2):189-95.
25. Tong GM, Rude RK. Magnesium deficiency in critical illness. J Intensive Care Med. 2005;20(1):3-17.
26. Iseri LT, Allen BJ, Brodsky MA. Terapia de magnesio en arritmias cardiacas en medicina de cuidados críticos. Revista de Cuidados Intensivo en Medicina. 2005;20(1):3-17.
27. Franz KB. A functional biological marker is needed for diagnosing magnesium deficiency. J Am Coll Nutr. 2004;23(6):738S-41S.
28. Moe SM. Disorders of calcium, phosphorus, and magnesium. Am J Kidney Dis. 2005;45(1):213-8.